首页> 外文OA文献 >Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study

【2h】

Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study

机译：日本型2型糖尿病患者的G蛋白偶联受体119激动剂DS-8500A的疗效和安全性具有不足的血糖对SITAGLIPTIN的血糖控制：A相随机安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yasuo Terauchi; Yuichiro Yamada; Hirotaka Watada; Yasuhiko Nakatsuka; Kazuhito Shiosakai; Takuo Washio; Takashi Taguchi;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of the G protein‐coupled receptor 119 agonist DS‐8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo‐controlled study [J] . Yasuo Terauchi, Yuichiro Yamada, Hirotaka Watada, Journal of diabetes investigation. . 2018,第6期

机译：G蛋白偶联受体119激动剂DS-8500a在西他列汀血糖控制不充分的日本2型糖尿病患者中的疗效和安全性：一项2期随机安慰剂对照研究
2. Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study [J] . Nobuya Inagaki, Shuji Tsukiyama, Takashi Taguchi, BMJ Open Diabetes Research & Care . 2017,第1期

机译：DS-2500a（一种G蛋白偶联受体119激动剂）在日本2型糖尿病患者中的降糖作用和安全性：一项随机，双盲，安慰剂对照，平行组，多中心，II期研究的结果
3. Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial [J] . Kaku K., Enya K., Nakaya R., Diabetes, obesity & metabolism . 2015,第7期

机译：在饮食和运动控制不充分的日本2型糖尿病患者中，G蛋白偶联受体40激动剂Fasiglifam（TAK-875）的疗效和安全性：一项随机，双盲，安慰剂对照的III期临床试验
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A randomized placebo-controlled trial of pioglitazone to improve metabolic control in adolescents with type 1 diabetes mellitus. [D] . Zdravkovic, Vera. 2005

机译：吡格列酮对改善1型糖尿病青少年的代谢控制的随机安慰剂对照试验。
6. Efficacy and safety of the G protein‐coupled receptor 119 agonist DS‐8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo‐controlled study [O] . Yasuo Terauchi, Yuichiro Yamada, Hirotaka Watada, 2018

机译：G蛋白偶联受体119激动剂DS-8500a在西他列汀血糖控制不充分的日本2型糖尿病患者中的疗效和安全性：一项2期随机安慰剂对照研究
7. Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise [O] . Michael A. Nauck, Murray W. Stewart, Christopher Perkins, 2015

机译：每周一次的GLP-1受体激动剂阿比鲁肽（HARMONY 2）的功效和安全性：52周主要终点来自一项随机，安慰剂对照试验，该试验针对饮食和运动控制不足的2型糖尿病患者

Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study

著录项

引文网络

相似文献

相关主题

期刊订阅